These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4270345)

  • 1. Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.
    Bradlow HL; Gillette PN; Gallagher TF; Kappas A
    J Exp Med; 1973 Oct; 138(4):754-63. PubMed ID: 4270345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Gallagher TF
    J Exp Med; 1972 Nov; 136(5):1043-53. PubMed ID: 4263649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect of steroid hormone metabolism in acute intermittent porphyria.
    Kappas A; Bradlow HL; Gillette PN; Levere RD; Gallagher TF
    Fed Proc; 1972; 31(4):1293-7. PubMed ID: 4261014
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in porphyria. VIII. Relationship of the 5 alpha-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria.
    Anderson KE; Bradlow HL; Sassa S; Kappas A
    Am J Med; 1979 Apr; 66(4):644-50. PubMed ID: 433969
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria.
    Casals G; Marcos J; Pozo ÓJ; Aguilera P; Herrero C; To-Figueras J
    Clin Biochem; 2013 Jun; 46(9):819-24. PubMed ID: 23499585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
    Sassa S; Granick S; Bickers DR; Bradlow HL; Kappas A
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):732-6. PubMed ID: 4522787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of postnatal development on drug-induced hepatic porphyria and the synthesis of cytochrome P-450. A biochemical and morphological study.
    Song CS; Moses HL; Rosenthal AS; Gelb NA; Kappas A
    J Exp Med; 1971 Nov; 134(5):1349-71. PubMed ID: 5112207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic porphyrias: new findings on the nature of metabolic defects.
    Meyer UA
    Prog Liver Dis; 1976; 5():280-93. PubMed ID: 775544
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G
    Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing primary from secondary Δ(4) -3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis.
    Yanagi T; Mizuochi T; Homma K; Ueki I; Seki Y; Hasegawa T; Takei H; Nittono H; Kurosawa T; Matsuishi T; Kimura A
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):346-51. PubMed ID: 25154774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of substances in human plasma capable of inducing the enzyme delta-aminolevulinate synthetase in liver cells.
    Kappas A; Song CS; Sassa S; Levere RD; Granick S
    Proc Natl Acad Sci U S A; 1969 Oct; 64(2):557-64. PubMed ID: 5261033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5α-reductase yielding 11β-hydroxy-5α-androstanedione.
    Swart AC; Schloms L; Storbeck KH; Bloem LM; Toit Td; Quanson JL; Rainey WE; Swart P
    J Steroid Biochem Mol Biol; 2013 Nov; 138():132-42. PubMed ID: 23685396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria.
    Pimstone NR; Blekkenhorst G; Eales L
    Enzyme; 1973; 16(1):354-66. PubMed ID: 4791054
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathways and genes involved in steroid hormone metabolism in male pigs: a review and update.
    Robic A; Faraut T; Prunier A
    J Steroid Biochem Mol Biol; 2014 Mar; 140():44-55. PubMed ID: 24239507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.
    Pozo OJ; Marcos J; Fabregat A; Ventura R; Casals G; Aguilera P; Segura J; To-Figueras J
    Orphanet J Rare Dis; 2014 Apr; 9():54. PubMed ID: 24735931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.